26 May 2013
Keywords: lilly, files, alimta, emea, nsclc, drug, major
Article | 01 October 2007
US drug major Eli Lilly & Co has submitted its anticancer agent Alimta (pemetrexed for injection) to the European Medicines Agency ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 October 2007
24 May 2013
© 2013 thepharmaletter.com